These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

396 related items for PubMed ID: 17531858

  • 21. Glatiramer acetate could be a potential therapeutic agent for Parkinson's disease through its neuroprotective and anti-inflammatory effects.
    Tsai SJ.
    Med Hypotheses; 2007; 69(6):1219-21. PubMed ID: 17548170
    [Abstract] [Full Text] [Related]

  • 22. Combination treatment of Glatiramer Acetate and Minocycline affects phenotype expression of blood monocyte-derived dendritic cells in Multiple Sclerosis patients.
    Ruggieri M, Pica C, Lia A, Zimatore GB, Modesto M, Di Liddo E, Specchio LM, Livrea P, Trojano M, Avolio C.
    J Neuroimmunol; 2008 Jul 15; 197(2):140-6. PubMed ID: 18555539
    [Abstract] [Full Text] [Related]

  • 23. Glatiramer acetate could be a hypothetical therapeutic agent for neuromyelitis optica.
    Wang KC, Lee CL, Chen SY, Lin KH, Tsai CP.
    Med Hypotheses; 2011 Jun 15; 76(6):820-2. PubMed ID: 21398045
    [Abstract] [Full Text] [Related]

  • 24. Copolymer-1.
    Comi G, Moiola L.
    Baillieres Clin Neurol; 1997 Oct 15; 6(3):495-509. PubMed ID: 10101586
    [Abstract] [Full Text] [Related]

  • 25. Brain-derived neurotrophic factor and TrkB receptor in experimental autoimmune encephalomyelitis and multiple sclerosis.
    De Santi L, Annunziata P, Sessa E, Bramanti P.
    J Neurol Sci; 2009 Dec 15; 287(1-2):17-26. PubMed ID: 19758606
    [Abstract] [Full Text] [Related]

  • 26. Putative mechanisms of action of statins in multiple sclerosis--comparison to interferon-beta and glatiramer acetate.
    Neuhaus O, Stüve O, Archelos JJ, Hartung HP.
    J Neurol Sci; 2005 Jun 15; 233(1-2):173-7. PubMed ID: 15949504
    [Abstract] [Full Text] [Related]

  • 27. Glatiramer acetate could be a potential antidepressant through its neuroprotective and anti-inflammatory effects.
    Tsai SJ.
    Med Hypotheses; 2007 Jun 15; 69(1):145-8. PubMed ID: 17196755
    [Abstract] [Full Text] [Related]

  • 28. Glatiramer acetate in multiple sclerosis: update on potential mechanisms of action.
    Farina C, Weber MS, Meinl E, Wekerle H, Hohlfeld R.
    Lancet Neurol; 2005 Sep 15; 4(9):567-75. PubMed ID: 16109363
    [Abstract] [Full Text] [Related]

  • 29. Glatiramer acetate (Copaxone).
    Francis DA.
    Int J Clin Pract; 2001 Sep 15; 55(6):394-8. PubMed ID: 11501229
    [Abstract] [Full Text] [Related]

  • 30. Glatiramer acetate-specific human CD8(+) T cells: increased IL-4 production in multiple sclerosis is reduced by glatiramer acetate treatment.
    Dressel A, Vogelgesang A, Brinkmeier H, Mäder M, Weber F.
    J Neuroimmunol; 2006 Dec 15; 181(1-2):133-40. PubMed ID: 17084909
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Peptidic complex mixtures as therapeutic agents in CNS autoimmunity.
    Shukaliak Quandt J, Borras E, Prat E, Gelderblom H, Houghten RA, Kashani A, Pinilla C, Stuerzebecher CS, Martin R.
    Mol Immunol; 2004 Feb 15; 40(14-15):1075-87. PubMed ID: 15036912
    [Abstract] [Full Text] [Related]

  • 37. Treatment of autoimmune neuroinflammation with a synthetic tryptophan metabolite.
    Platten M, Ho PP, Youssef S, Fontoura P, Garren H, Hur EM, Gupta R, Lee LY, Kidd BA, Robinson WH, Sobel RA, Selley ML, Steinman L.
    Science; 2005 Nov 04; 310(5749):850-5. PubMed ID: 16272121
    [Abstract] [Full Text] [Related]

  • 38. Multiple sclerosis: glatiramer acetate induces anti-inflammatory T cells in the cerebrospinal fluid.
    Hestvik AL, Skorstad G, Price DA, Vartdal F, Holmoy T.
    Mult Scler; 2008 Jul 04; 14(6):749-58. PubMed ID: 18611988
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Clinical response to glatiramer acetate correlates with modulation of IFN-gamma and IL-4 expression in multiple sclerosis.
    Valenzuela RM, Costello K, Chen M, Said A, Johnson KP, Dhib-Jalbut S.
    Mult Scler; 2007 Jul 04; 13(6):754-62. PubMed ID: 17613604
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.